Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
Antiviral CD8(+) T cells are thought to play a significant role in limiting the viremia of human and simian immunodeficiency virus (HIV and SIV, respectively) infections. However, it has not been possible to measure the in vivo effectiveness of cytotoxic T cells (CTLs), and hence their contribution to the death rate of CD4(+) T cells is unknown. Here, we estimated the ability of a prototypic antigen-specific CTL response against a well-characterized epitope to recognize and kill infected target cells by monitoring the immunodominant Mamu-A*01-restricted Tat SL8 epitope for escape from Tat-specific CTLs in SIVmac239-infected macaques. Fitting a mathematical model that incorporates the temporal kinetics of specific CTLs to the frequency of Tat SL8 escape mutants during acute SIV infection allowed us to estimate the in vivo killing rate constant per Tat SL8-specific CTL. Using this unique data set, we show that at least during acute SIV infection, certain antiviral CD8(+) T cells can have a significant impact on shortening the longevity of infected CD4(+) T cells and hence on suppressing virus replication. Unfortunately, due to viral escape from immune pressure and a dependency of the effectiveness of antiviral CD8(+) T-cell responses on the availability of sufficient CD4(+) T cells, the impressive early potency of the CTL response may wane in the transition to the chronic stage of the infection.
Mandl
Judith N
JN
Graduate Program in population Biology, Ecology, and Evolution, Emory University, 954 Gatewood Road, Atlanta, GA 30329, USA.
Regoes
Roland R
RR
Garber
David A
DA
Feinberg
Mark B
MB
D000595:Amino Acid Sequence; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D000939:Epitopes / Q000737:chemistry; D007107:Immune System / Q000821:virology*; D008253:Macaca mulatta; D008954:Models, Biological; D015233:Models, Statistical; D008962:Models, Theoretical; D008969:Molecular Sequence Data; D009154:Mutation; D015302:Simian Immunodeficiency Virus / Q000235:genetics*; D013997:Time Factors; D014773:Virology / Q000379:methods*
D000939:Epitopes
Nature. 1995 Jan 12;373(6510):117-22
7529365
J Immunol. 2007 Sep 1;179(5):3026-34
17709517
J Virol. 1995 Aug;69(8):5087-94
7541846
J Virol. 1996 Nov;70(11):7894-9
8892912
Nat Med. 1997 Feb;3(2):205-11
9018240
Curr Biol. 1997 Mar 1;7(3):R136-40
9162473
AIDS. 1998;12 Suppl A:S35-42
9632982
J Immunol. 1998 Jun 15;160(12):6062-71
9637523
J Exp Med. 1999 Mar 15;189(6):991-8
10075982
J Immunol. 1999 May 1;162(9):5127-33
10227983
J Virol. 2005 May;79(9):5721-31
15827187
Nature. 2005 Apr 28;434(7037):1093-7
15793563
Nature. 2005 Apr 28;434(7037):1148-52
15793562
J Virol. 2005 Nov;79(21):13579-86
16227278
J Virol. 2005 Dec;79(23):14986-91
16282500
Nat Med. 2006 Mar;12(3):289-95
16520776
Virology. 2006 Mar 30;347(1):140-6
16387340
PLoS Biol. 2006 Apr;4(4):e90
16515366
PLoS Comput Biol. 2006 Mar;2(3):e24
16604188
J Virol. 2006 Oct;80(19):9861-4
16973590
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1599-603
17242364
J Virol. 2007 Mar;81(6):2624-34
17192314
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6365-70
17404226
Immunol Cell Biol. 2007 Jun;85(4):274-9
17420769
Nature. 2000 Sep 21;407(6802):386-90
11014195
Nature. 2001 Apr 19;410(6831):980-7
11309628
J Virol. 2001 Dec;75(24):11983-91
11711588
Proc Biol Sci. 2002 Sep 22;269(1503):1887-93
12350250
Nat Immunol. 2002 Nov;3(11):1061-8
12368910
J Virol. 2002 Dec;76(23):12173-84
12414957
J Virol. 2003 Feb;77(3):2081-92
12525643
J Virol. 2003 Apr;77(8):4911-27
12663797
J Virol. 2003 Apr;77(8):5037-8
12663814
J Immunol. 2003 Oct 1;171(7):3837-46
14500685
J Virol. 2003 Dec;77(23):12572-8
14610180
J Virol. 2004 Mar;78(5):2581-5
14963161
Nat Med. 2004 Mar;10(3):282-9
14770175
Nat Med. 2004 Mar;10(3):275-81
14966520
J Virol. 2004 Apr;78(7):3233-43
15016844
J Clin Invest. 2004 Mar;113(6):836-45
15067316
J Virol. 2004 May;78(9):4866-75
15078967
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5640-5
15064398
Lancet Infect Dis. 2004 Jul;4(7):397-413
15219551
Nat Rev Immunol. 2004 Aug;4(8):630-40
15286729
J Virol. 1989 Sep;63(9):3708-13
2760980
AIDS. 1990 Nov;4(11):1095-103
2282182
Proc Natl Acad Sci U S A. 1991 May 1;88(9):4045-9
2023953
AIDS Res Hum Retroviruses. 1994 Feb;10(2):213-20
8198874
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
Nature. 1995 Jan 12;373(6510):123-6
7816094